Therapeutic Solutions International Announces Launching of Phase III Clinical Trial for Treating COV
Landmark Study Aimed to Support FDA Registration of First Cell Therapy with Dual Anti-inflammatory and Lung Healing Mechanism of ActionOCEANSIDE, Calif.--(BUSINESS WIRE)--Therapeutic Solutions International announced today the launching of a double-blind, randomized, placebo controlled, multi-center, multi-nation, c...
Timothy Dixon Thomas Ichim James Veltmeyer Chris Obrien Therapeutic Solutions International Inc Board Member Of The Company
Source: pharmiweb.com